VYD-2311 is under clinical development by Invivyd and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Simaravibart is under clinical development by Contraria Biotech and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

Long COVID, a condition that causes symptoms such as fatigue and brain fog months after infection, affects millions and ...

COVID-19 infection is not associated with immediate changes in multiple sclerosis (MS) symptom severity or disability.

Wen: The majority of people with diarrhea, vomiting and stomach cramps have viral gastroenteritis caused by the very ...

Speculation about the alleged findings of a study on long COVID and post-vaccination syndrome spread widely among vaccine ...

Parkinson’s disease (PD) may lead to an increased risk of developing severe illness and a more complicated recovery from a COVID-19 infection. Generally, respiratory infections such as pneumonia can ...

In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader who had success treating toenail fungus with Polysporin.

Some 16 states had "very high" levels of the virus present in wastewater during the week of Christmas, an increase from the week before.

A statewide grand jury convened at the request of Florida Gov. Ron DeSantis has found no evidence of criminal activity ...

COVID-19 is a respiratory disease primarily affecting the lungs. However, the SARS-CoV-2 virus that causes COVID-19 surprised ...

While there is a whole host of viruses going around, there are thankfully no new viruses to fret about—the ones we have are ...